Limited ResearchHealing & Recovery

Tri-Heal Max Protocol

Tri-Heal Max

High-Dose Three-Peptide Healing Blend

Half-life

Not reported

Chain length

Not applicable (peptide combination)

Reference frequency

Once daily

Research overview

DoseGear research brief

Tri-Heal Max is an enhanced healing peptide blend featuring a higher dose of TB-500 (25mg) combined with BPC-157 (10mg) and KPV (10mg) for a total of 45mg per vial. This formulation emphasizes TB-500's tissue repair and cellular migration properties, complemented by BPC-157's growth factor upregulation and KPV's anti-inflammatory effects. The higher TB-500 ratio (2. 5:1:1) compared to standard healing stacks targets more significant tissue damage or accelerated recovery needs.

Mechanism of action

Each peptide contributes distinct healing pathways: TB-500 (Thymosin Beta-4) enhances cellular migration, promotes actin polymerization, and supports blood vessel formation for tissue repair; BPC-157 upregulates growth factors (VEGF, EGF), accelerates wound healing, and provides gastrointestinal protection; KPV (alpha-MSH fragment) inhibits the NF-κB inflammatory pathway, reduces pro-inflammatory cytokines, and may improve injection site tolerability. Together, they address inflammation, tissue regeneration, and cellular repair.

Compound background

Development & research timeline

Study windows describe what researchers measured, not when an individual should expect a result.

Origin & development

Marketed TB-500, BPC-157, and KPV blend; a specific developer is not established.

What it is researched for

Proposed tissue-repair and inflammation applications based on ingredient mechanisms; synergy is unestablished.

Research observation window

Not reported for the blend.

Reference data

Lyophilized vial injectable protocols

Not personalized dosing instructions

Only injectable vial references are shown. Nasal, topical, and unsupported non-vial schedules are excluded.

No sourced lyophilized-vial injectable protocol is listed for this profile.

Safety context

Reported side effects

Injection site reactions (KPV may help reduce these)
Mild fatigue during healing
Temporary redness at injection site

Contraindications & cautions

No clinical trials on this three-peptide combination
Active cancer (theoretical concern with growth-promoting peptides)
Pregnancy or breastfeeding
Active infection at injection site

Scientific references

01
Thymosin Beta-4 (TB-500) Tissue Repair
Scientific citationThymosin Beta-4 (TB-500) Tissue Repair. .
02
BPC-157 Healing Properties
Scientific citationBPC-157 Healing Properties. .
03
KPV Anti-Inflammatory Effects
Scientific citationKPV Anti-Inflammatory Effects. .
04
No Published Studies on Tri-Heal Max Combination
Scientific citationNo Published Studies on Tri-Heal Max Combination. (2024).

This DoseGear profile combines published scientific literature with lyophilized-vial protocol references. Citations are provided for independent review.

Related research profiles

Healing & Recovery